Portfolio company
Briefly Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Briefly Bio develops AI software to capture, standardise, and share laboratory protocols for scientists in the biotechnology and pharmaceutical industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioRaptor
BioRaptor develops an AI-driven bioprocessing data platform for biotechnology, biopharmaceutical and food-tech companies to automate experiment analysis and optimise production yields.
UniteLabs
UniteLabs develops a software platform that connects diverse laboratory instruments into a programmable system for biotechnology and pharmaceutical research and development organisations.
Spaero
This company develops robot-agnostic software to automate biological experiments and laboratory workflows for scientists.
BioReact
BioReact develops artificial intelligence software to automate data analysis and parameter optimization for bioprocess engineers and biotechnology companies.
Spaero Bio
This company develops robot-agnostic software systems to automate biological research protocols and experiments for life sciences and biotechnology customers.
Kiin Bio
This company develops an artificial intelligence platform of virtual scientists to automate and coordinate drug discovery workflows for biotechnology firms and academic researchers.
Bioqore
The company develops AI-driven bioprocessing models and automated wet lab services to optimise drug manufacturing conditions for biotechnology and pharmaceutical companies.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.